Abekma, Breyanzi, CARVYKTI, Qimriyo, Tekartus, Yeskarta
Insonga asoslangan CAR T hujayra terapiyasi: yutuqlar va muammolar
Kirish Onkologiya sohasida immunoterapiya xavfli o'smalarga qarshi kurashish uchun tananing immun tizimini qo'llaydigan kashshof metodologiya sifatida paydo bo'ldi. Ko'p immunoterapevtik yondashuvlar mavjud, ammo Ximerik Antigen Rece..
Brexucabtagene autoleucel, Yevropa Ittifoqi, Gil'ad, Kite, Tekartus
Tecartus relapsli yoki refrakter o'tkir limfoblastik leykemiyani davolash uchun Evropaning marketing ruxsatini oldi.
Sept 2022: The European Commission (EC) has authorized Kite's CAR T-cell therapy Tecartus® (brexucabtagene autoleucel) for the treatment of adult patients 26 years of age and older with relapsed or refractory (r/r) B-cell precurs..
balli, Brexucabtagene autoleucel, Ural farma, Tekartus, ZUMA-3
Brexucabtagene autoleucel relapsli yoki refrakter B-hujayrali prekursorli o'tkir limfoblastik leykemiya uchun FDA tomonidan tasdiqlangan.
2021 yil oktyabr: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) Oziq-ovqat va farmatsevtika idorasi tomonidan relapsli yoki refrakter B-hujayrali prekursorli o'tkir limfoblastik leykemiya (ALL) bo'lgan kattalar bemorlari uchun tasdiqlangan. In..
Akalabrutunib, Avelumab, KART terapiyasi, Dabrafanib, Qimriyo, Eng so'nggi dorilar, Midostaurin, Niraparib, Pembrolizumab, Tekartus, Tisagenlekleusel, Trametinib, USFDA
Saraton kasalligini davolashda eng yangi dorilar
2021 yil iyul: Saraton kasalligini davolashda eng so'nggi dorilarni ko'rib chiqing. Har yili, sinovlar va boshqa muhim omillarni o'rganib chiqqandan so'ng, USFDA dori-darmonlarni tasdiqlaydi va shuning uchun saraton bemorlari endi davolanish juda yaqin ekanligiga ishonishlari mumkin. ..